Abiopharma

LEWIS JOEL 🔴 sold 56.3K shares of GALECTIN THERAPEUTICS INC (GALT) at $3.88 Transaction Date: Jan 05, 2026 | Filing ID: 000010

(100% Positive) Biofrontera Inc. (BFRI) Reports Q1 2026 Financial Results

(70% Positive) IDEXX Laboratories Inc. (IDXX) Files Form 8-K

Biofrontera Notification (BFRI)

(75% Positive) Avita Medical Ltd (RCEL) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process

IDEXX Announces CEO Succession

(10% Negative) Rewalk Robotics Ltd (LFWD) Announces Clinical Trial Timeline Adjustment

(75% Positive) Charles River Laboratories International Inc. (CRL) Reports Q1 2026 Financial Results

EPAM Systems, Inc. - EPAM to Host Investor Day on March 12, 2026

Ginkgo Bioworks - Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Edgewise Therapeutics - Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026

Omnicell - Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Johnson & Johnson - Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Natera - Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling

Alto Neuroscience, Inc. - Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology